ALB and cancer: Several peripheral blood markers have been shown to correlate with cancer prognosis, including the platelet-albumin ratio (PAR), platelet-lymphocyte ratio (PLR), albumin-fibrinogen ratio (AFR), lymphocyte-monocyte ratio (LMR), neutrophil-lymphocyte ratio (NLR), aspartate aminotransferase-alanine aminotransferase ratio (SLR), and D-dimer (9, 11).